Bethesda, MD, US
Mid-Sized Business (10-100M TTM Revenue)
Evidera was formed in 2013 when Symphony Technology Group (STG), a private equity firm focused on technology and services, acquired the health economics (HE), outcomes research (OR), market access, epidemiology and data analytics practices of United BioSource Corporation (UBC), a wholly owned subsidiary of Express Scripts Holding Company. Evidera has over 30 year of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group and Archimedes.
Evidera’s 300 researchers and consultants have expertise working in all developed and many developing countries.
U.S. headquarters in Bethesda, MD (Washington, D.C.)
European headquarters in London
Primary offices in Boston, Budapest, Harrisburg, Montreal, San Francisco and Seattle
|Evidera Ltd 201 Talgarth Rd Hammersmith, London, W6 8BJ United Kingdom|
|Evidera, Inc. 7101 Wisconsin Ave Bethesda, MD, 20814 United States|
|Evidera 1 Butterwick London, England, W6 8DL United Kingdom|
|Evidera 430 Bedford Street Lexington, MA, 02420 United States|
|Evidera 450 Sansome Street San Francisco, CA, 94111 United States|
To request access, simply fill out the form below and we will contact you.